Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Oral administration offers greater convenience for patients who require long-term treatment and is more appealing for those with a fear of injections 2,3,4,5
For weight management: BMI of 30 or greater (obesity), OR BMI of 27 or greater with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea) For type 2 diabetes: Diagnosis of type 2 diabetes Inadequate glycemic control on current therapy Understanding how to qualify for GLP-1 medications helps navigate the process
If you have struggled with obesity for a long time, it is not recommended that you stop taking GLP-1 medication
Employers that currently exclude bariatric surgery from their benefits should consider adding coverage for this procedure
No irritation, no purging, just calm, clear progress
Some patients develop small bumps under the skin called lipohypertrophy when they repeatedly inject into the same spot
US$ 26.78
US$ 26.44
US$ 21.52
